Thorsgaard Pedersen N, Halgreen H
Gastroenterology. 1985 Jan;88(1 Pt 1):47-54. doi: 10.1016/s0016-5085(85)80131-1.
[14C]Triolein and [3H]oleic acid are useful tracers of dietary triglycerides and free fatty acids. The combustion/liquid scintillation counting technique was found a practicable method of estimating the fecal activity of these tracers. When ingested with the nonabsorbable marker 51CrCl3, the fecal excretion of 14C and 3H could be estimated accurately from samples of two stools. This technique was investigated as a test of lipid assimilation in a prospective, blind study of 84 consecutive patients suspected of malassimilation. The fecal excretion of 14C was a useful alternative to fecal fat: the patients with "normal lipid assimilation" excreted less than or equal to 10.4% of the dose ingested, whereas 25 of the 26 patients with steatorrhea ("unequivocal malassimilation") excreted greater than 10.4%. Fecal fat was normal in 18 patients who exhibited other signs of malassimilation ("equivocal malassimilation"); in 5 of these patients fecal excretion of 14C was greater than 10.4%. Lastly, there was a significant correlation between fecal 14C and fecal fat (r = 0.82, p less than 0.001). The fecal 14C/3H ratio was found useful as an index of pancreatic digestive function, being less than 1.3 in patients with "normal" lipid digestion and greater than or equal to 1.3 in 18 of the 19 patients with pancreatic steatorrhea and in 19 of the 27 patients with severely reduced exocrine pancreatic function. The test result was found widely independent either of the amount of carrier fat or the quality of the fecal collections and was therefore useful as an outpatient test. As it provided information about the pathogenesis of malassimilation and was at least as sensitive and specific as a fat "balance study," the test may be a useful alternative to fecal fat measurement.
[14C]三油酸甘油酯和[3H]油酸是膳食甘油三酯和游离脂肪酸的有用示踪剂。燃烧/液体闪烁计数技术被发现是一种估算这些示踪剂粪便活性的可行方法。当与不可吸收标记物51CrCl3一起摄入时,通过两份粪便样本可以准确估算14C和3H的粪便排泄量。在一项对84例连续怀疑存在消化吸收不良的患者进行的前瞻性、盲法研究中,对该技术作为脂质同化测试进行了研究。14C的粪便排泄量是粪便脂肪的一种有用替代指标:“脂质同化正常”的患者排泄量小于或等于摄入剂量的10.4%,而26例脂肪泻患者(“明确的消化吸收不良”)中有25例排泄量大于10.4%。18例表现出其他消化吸收不良迹象(“可疑的消化吸收不良”)的患者粪便脂肪正常;其中5例患者14C的粪便排泄量大于10.4%。最后,粪便14C与粪便脂肪之间存在显著相关性(r = 0.82,p < 0.001)。发现粪便14C/3H比值作为胰腺消化功能指标很有用,“正常”脂质消化的患者该比值小于1.3,19例胰腺性脂肪泻患者中有18例以及27例胰腺外分泌功能严重降低的患者中有19例该比值大于或等于1.3。研究发现测试结果在很大程度上与载体脂肪量或粪便收集质量无关,因此作为门诊测试很有用。由于它提供了有关消化吸收不良发病机制的信息,并且至少与脂肪“平衡研究”一样敏感和特异,该测试可能是粪便脂肪测量的一种有用替代方法。